Filing Details
- Accession Number:
- 0001104659-12-047932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-06 17:29:18
- Reporting Period:
- 2012-07-03
- Filing Date:
- 2012-07-06
- Accepted Time:
- 2012-07-06 17:29:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1491576 | Tesaro Inc. | TSRO | Pharmaceutical Preparations (2834) | 272249687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1207833 | L Arnold Oronsky | C/O Tesaro, Inc. 1000 Winter Street, Suite 3300 Waltham MA 02451 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-03 | 2,627,257 | $0.00 | 2,627,257 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2012-07-03 | 444,444 | $13.50 | 3,071,701 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2012-07-03 | 9,195,402 | $0.00 | 2,627,257 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect |
Footnotes
- The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- Reflects a 1-for-3.5 reverse stock split which became effective prior to the closing of the Issuer's initial public offering.
- The shares are held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10. The Reporting Person is a managing director of IMP10. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.